ABSTRACT: SYNOPSIS: (Figure is included in full-text article.)Podocyte-specific PHB2 loss results in severe kidney disease that is alleviated by insulin and IGF-1 receptors deletion or rapamycin treatment, demonstrating not only a causal link between mitochondrial dysfunction and kidney disease but also putative therapeutic avenues.(Figure is included in full-text article.)